Meriwether Wealth & Planning’s AstraZeneca AZN Stock Holding History

Meriwether Wealth & Planning’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$14.2K	Buy	+88	New	+$14.7K	0.01%	378

Other funds holding AZN

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return

ASR Vermogensbeheer Utrecht, Netherlands $10.1B AUM 30.4% 1-Year Est. Return

Generali Asset Management Trieste, Italy $5.73B AUM 29.6% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

ZWJ Investment Counsel Atlanta, Georgia $3.24B AUM 31.6% 1-Year Est. Return

Meriwether Wealth & Planning's AZN Position: Q3 2026 in Review

Meriwether Wealth & Planning opened a new position in AstraZeneca (AZN) in Q3 2026: 88 shares worth $14.2K. The stake represents 0.01% of the portfolio and ranks #378 among its holdings.

501 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

Meriwether Wealth & Planning held 88 shares of AstraZeneca worth $14.2K as of Q3 2026.
AstraZeneca was a new Meriwether Wealth & Planning position in Q3 2026.
AstraZeneca made up 0.01% of Meriwether Wealth & Planning's portfolio in Q3 2026, its #378 holding.
501 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Meriwether Wealth & Planning's 13F filing for Q3 2026, filed 13 Oct 2026.